Dicerna (DRNA) up 78% Today. Being Acquired by Novo Nordisk (NVO) for $38.00.
We shoot and we score. Up 1,133% since adding to Watch List @ $3.00.
Our second...
The Alkaline Water Company (WTER) Reports Record Second Quarter Revenue with 50% Year over...
$15.25 Million in Revenue is Best Quarter in Company History
SCOTTSDALE, Ariz., November 09, 2021–(BUSINESS WIRE)–The Alkaline Water Company...
Beachbody (BODY) Conference Call
"Make no mistake, as the single largest shareholder as well as CEO of Beachbody, but more so because I believe in the...
Adding Beach Body (BODY) $3.90 to the Watch List.
This is Like Shooting Fish in the Barrell, but the Fish Shoot Back.
We’re not traders, but we...
Avicanna (AVCNF) $0.60 Conference Call.
8:30EST This Morning, Friday 11/12/21
Avicanna Inc. to Host Third Quarter 2021 Investor Conference Call.
TORONTO,...
Nautilus (NLS) $8.50, Numbers Out. Time to go Bottom Fishing?
Adding Nautilus to the Watch List. Conference Call Transcript Below
New Street Targets at $15 per Share.
Peloton Plunges $9 Billion in Value, on a $805 Million Quarter!
Peloton just reported the $805 million for three months worth of business ended September. That's $9 million worth of fitness everyday. And...
Revive Therapeutics (RVVTF, RVV.CN) in Discussions to Secure Supply of 5 Billion Bucillamine Tablets.
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19
Not wanting to be caught...
Cybin (CYBN) Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using...
October 26, 2021 07:30 AM Eastern Daylight Time
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biotechnology...
Society Pass News Archive
1-24-2023: Initiating Coverage on Society Pass (SOPA).
1-24-2023: Society Pass (SOPA) Research Reports
1-12-2023: Adding Society...
Latest article
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...
Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...
